SLC4A1 (AE1) |
Erythrocytes, kidney, heart, colon |
Cl−/ exchanger |
Hemolytic anemia, distal renal tubular acidosis |
|
Inhibitor: DIDS |
Bruce et al., 1997; Jarolim et al., 1998; Karet et al., 1998; Shayakul and Alper, 2004; Stehberger et al., 2007; Romero et al., 2013
|
SLC4A2 (AE2) |
Most epithelial cells |
Cl−/ exchanger |
Osteopetrosis |
|
Inhibitor: DIDS |
Gawenis et al., 2004; Romero et al., 2013
|
SLC4A3 (AE3) |
Brain, kidney, GI tract, smooth muscle and heart |
Cl−/ exchanger |
Epilepsy, blindness |
Lower seizure threshold |
Inhibitor: DIDS |
Sander et al., 2002; Hentschke et al., 2006; Romero et al., 2013; Ruffin et al., 2014
|
SLC4A8 (NDCBE) |
Brain, kidney, testes and ovary |
Na+–dependent Cl−/ exchanger, acid extruder |
? |
|
Inhibitor: DIDS |
Chen et al., 2008; Burette et al., 2012
|
SLC4A10 (NCBE) |
Brain |
pH regulation (acid extrusion) |
? |
Higher seizure threshold, volume reduction of brain ventricles |
Inhibitor: DIDS |
Chen et al., 2008; Jacobs et al., 2008; Liu et al., 2011; Romero et al., 2013
|